Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pain × Ropivacaine × Clear all

Phase

Phase 3 3 Phase NA 2 Phase 4 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 1 Pain 1 Neoplasms 1 Lung Neoplasms 1 Feeding and Eating Disorders 1 Agnosia 1

Interventions

Analgesia 6 Morphine 5 nabiximols 3 Pregabalin 3 Oxycodone 3 Fentanyl 3 ziconotide 2 Surveys and Questionnaires 2 Saline Solution 2 Radiofrequency Ablation 2 Methadone 2 Lidocaine 2 Ibandronic Acid 2 Duloxetine Hydrochloride 2 Docetaxel 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 tanezumab 1 tandutinib 1 siltuximab 1 resiniferatoxin 1 incobotulinumtoxinA 1 imisopasem manganese 1 fulranumab 1 erenumab 1 cyclobenzaprine 1 caffeine, sodium benzoate drug combination 1 Therapeutics 1 Tapentadol 1 Sulindac 1 Soybean Proteins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated

Feeding and Eating Disorders, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡